Investigation of Cytotoxic Effects of Recombinant Human Interferon Lambda-1 and Its Pegylated Form on Human Conjunctival Epithelial Cells
Currently, there are no efficacious, all-purpose antiviral medicines for the treatment of ocular surface infections caused by viruses. At the same time, type III interferons demonstrate high potency for histological barriers, such as the conjunctiva. Modification of protein molecules in native produ...
Main Authors: | N. A. Kikhtenko, N. A. Bondarenko, N. P. Bgatova, L. A. Oleynik, O. V. Poveshchenko, A. Zh. Fursova, P. G. Madonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2021-12-01
|
Series: | Безопасность и риск фармакотерапии |
Subjects: | |
Online Access: | https://www.risksafety.ru/jour/article/view/240 |
Similar Items
-
Investigation of the antiviral activity of the recombinant human interferon lambda 1 in human conjunctiva cell culture
by: N. A. Kikhtenko, et al.
Published: (2021-10-01) -
Interferons lambda – therapeutic application
by: N. A. Kikhtenko, et al.
Published: (2020-05-01) -
Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha
by: Andréa Marques Vieira da Silva, et al.
Published: (2021-07-01) -
Conjunctival squamous papilloma refractory to interferon α-2b in a patient on systemic immunosuppression (tacrolimus)
by: Preethi S. Ganapathy, et al.
Published: (2017-06-01) -
The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C
by: Maryam Keshvari, et al.
Published: (2016-01-01)